Navigation Links
Concert Medical Launches 'Conductor™' Family of Interventional Coronary Guidewires
Date:7/14/2010

NORWELL, Mass., July 14 /PRNewswire/ -- Concert Medical, LLC today announced the launch of the "Conductor™" family of Interventional Coronary Guidewires to the U.S. market. These guidewires are designed to address an extensive range of coronary disease cases at a superior value. The FDA granted Concert Medical clearance for the use and sale in the U.S. of the Conductor product line in September 2009. Concert Medical is located in Norwell, Mass. and manufactures all of its interventional products in the United States.

Concert Medical is an integrated medical device manufacturer, directly controlling all design and critical manufacturing processes for its interventional products. This business integration ensures both product quality and greater value. Concert's Conductor guidewires offer enhanced trackability and crossability, with an increased reliable strength and superior torque response. Performance-enhancing design features include a proprietary hydrophilic coating to improve tactile feel and shaft markers at 90cm and 100cm for precise insertion measurement.

Howard Donnelly, President of Concert Medical, said the Conductor is the firm's second guidewire product released in 2010.  "Earlier this year we launched a private-labeled neurological guidewire, co-developed with a leading medical device company," noted Donnelly. "The Conductor, which we spent two years developing, is an outstanding addition to our interventional guidewire business."

Concert Medical, formerly The MicroSpring Company, was founded in 1982 as an exclusively contract manufacturer and was acquired by Donnelly and his partners in 2005. Since the acquisition, Donnelly has moved Concert from a contract manufacturer to a private label and proprietary medical device product developer.  "Whether it's for our own product line or private labeled for a customer, we add a lot of value to the design and manufacturing of medical products," noted Donnelly. "With close to 30 years of experience in the fields of Interventional Cardiology and Interventional Neurology, we have the knowledge, expertise, and resources to bring innovative products and updates to the marketplace."

Interventional Cardiologists interested in the Conductor can contact Emily O'Connor, Product Manager, at 781-871-7882, x151 or at emily.oconnor@concertmedical.com. For additional information on Concert Medical and its products, visit www.concertmedical.com.


'/>"/>
SOURCE Concert Medical, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Watson Says Appeals Court Affirms Concerta(R) Patent Invalid
2. CONCERTA(R) Patent Appeal Denied
3. CONCERTA(R) in the Classroom: New Data on Attention in Children With ADHD
4. Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD Patients Day
5. New Study of Concerta(R) Showed Significant Improvement of ADHD Symptom Management in Adults Compared to Placebo
6. Varian Medical Systems to Showcase Fast, Precise Brachytherapy Planning System at Annual Meeting of American Association of Physicists in Medicine
7. Parkview Medical Center Selects MobileMD for Health Information Exchange Service
8. Medical Alarm Concepts™ Announces Roll-Out of the MediPendant™ at Albertsons
9. Dehaier Medical Systems Acquires Emergency Ventilator Series to Extend Product Line
10. New White Paper Helps Medical Device Manufacturers Apply New FDA Regs to Combination Products
11. Crux Biomedical Named One of Top 50 Companies to Watch
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... India , June 24, 2016 ... Needles Market by Type (Standard Pen Needles, Safety Pen ... Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, ... by MarketsandMarkets, This report studies the market for the ... expected to reach USD 2.81 Billion by 2021 from ...
(Date:6/24/2016)... Tenn. , June 24, 2016  Arkis ... providing less invasive and more durable cerebrospinal fluid ... in funding.  The Series-A funding is led by ... Lighthouse Fund, and other private investors.  Arkis, new ... neurosurgical instrumentation and the market release of its ...
(Date:6/23/2016)... HILLS, Calif. , June 23, 2016 Any ... the many challenges of the current process. Many of them ... because of the technical difficulties and high laboratory costs involved. ... have to offer it at such a high cost that ... afford it. Dr. Parsa Zadeh , founder ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... ... BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a ... an hour by 2020 and then adjusting it yearly to increase at the same rate ... assure the wage floor does not erode again, and make future increases more predictable. , ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... the Clinical Decision Making in Emergency Medicine conference in Ponte Vedra Beach, FL. ... articles published in Emergency Medicine Practice and Pediatric Emergency Medicine Practice. ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Grove Investment Group (TGIG), has initiated cultivation and processing operations at its production ... and Pahrump, Nevada. , Puradigm is the manufacturer of a complete system of ...
(Date:6/24/2016)... ... ... National recruitment firm Slone Partners is pleased to announce the ... as Vice President of North American Capital Sales at HTG Molecular . ... team in the commercialization of the HTG EdgeSeq system and associated reagents in North ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... human induced pluripotent stem (iPS) cells and other difficult to transfect cells, announces ... Medium. The PluriQ™ G9™ Gene Editing System is a complete system ...
Breaking Medicine News(10 mins):